David Slack - Jan 9, 2023 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Role: President & CBO, Director
Signature: James Nisco, Attorney-in-fact for David Slack
Stock symbol: LSTA
Transactions as of: Jan 9, 2023
Transactions value $: -$10,074
Form type: 4
Date filed: 1/11/2023, 03:10 PM
Previous filing: Sep 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LSTA	Common Stock	Award	$0	+24K		$0.00	24K	Jan 9, 2023	Direct	F1, F2
transaction	LSTA	Common Stock	Tax liability	-$10.1K	-3.36K	-13.99%	$3.00	20.6K	Jan 9, 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LSTA	Stock Options (Right to Buy)	Award	$0	+12K		$0.00	12K	Jan 9, 2023	Common Stock	12K	$3.00	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 24,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2	Includes 18,000 unvested restricted stock.
F3	Shares withheld as payment of a tax liability on vesting of restricted stock.
F4	One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.